SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    A. McNeill, J. Magalhaes, C. Shen, K.-Y. Chau, D. Hughes, A. Mehta, T. Foltynie, J. M. Cooper, A. Y. Abramov, M. Gegg, A. H. V. Schapira, Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells, Brain, 2014, 137, 5, 1481

    CrossRef

  2. 2
    Elena Antelmi, Giovanni Rizzo, Margherita Fabbri, Sabina Capellari, Cesa Scaglione, Paolo Martinelli, Arylsulphatase A activity in familial parkinsonism: a pathogenetic role?, Journal of Neurology, 2014, 261, 9, 1803

    CrossRef

  3. 3
    Yuanzhe Li, Takeshi Sekine, Manabu Funayama, Lin Li, Hiroyo Yoshino, Kenya Nishioka, Hiroyuki Tomiyama, Nobutaka Hattori, Clinicogenetic study of GBA mutations in patients with familial Parkinson's disease, Neurobiology of Aging, 2014, 35, 4, 935.e3

    CrossRef

  4. 4
    J. Bras, R. Guerreiro, L. Darwent, L. Parkkinen, O. Ansorge, V. Escott-Price, D. G. Hernandez, M. A. Nalls, L. N. Clark, L. S. Honig, K. Marder, W. M. Van Der Flier, A. Lemstra, P. Scheltens, E. Rogaeva, P. St George-Hyslop, E. Londos, H. Zetterberg, S. Ortega-Cubero, P. Pastor, T. J. Ferman, N. R. Graff-Radford, O. A. Ross, I. Barber, A. Braae, K. Brown, K. Morgan, W. Maetzler, D. Berg, C. Troakes, S. Al-Sarraj, T. Lashley, Y. Compta, T. Revesz, A. Lees, N. Cairns, G. M. Halliday, D. Mann, S. Pickering-Brown, D. W. Dickson, A. Singleton, J. Hardy, Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies, Human Molecular Genetics, 2014, 23, 23, 6139

    CrossRef

  5. 5
    Hao Deng, Xiaofei Xiu, Joseph Jankovic, Genetic Convergence of Parkinson’s Disease and Lysosomal Storage Disorders, Molecular Neurobiology, 2014,

    CrossRef

  6. 6
    M. Siebert, E. Sidransky, W. Westbroek, Glucocerebrosidase is shaking up the synucleinopathies, Brain, 2014, 137, 5, 1304

    CrossRef

  7. 7
    N. E. Mencacci, I. U. Isaias, M. M. Reich, C. Ganos, V. Plagnol, J. M. Polke, J. Bras, J. Hersheson, M. Stamelou, A. M. Pittman, A. J. Noyce, K. Y. Mok, T. Opladen, E. Kunstmann, S. Hodecker, A. Munchau, J. Volkmann, S. Samnick, K. Sidle, T. Nanji, M. G. Sweeney, H. Houlden, A. Batla, A. L. Zecchinelli, G. Pezzoli, G. Marotta, A. Lees, P. Alegria, P. Krack, F. Cormier-Dequaire, S. Lesage, A. Brice, P. Heutink, T. Gasser, S. J. Lubbe, H. R. Morris, P. Taba, S. Koks, E. Majounie, J. Raphael Gibbs, A. Singleton, J. Hardy, S. Klebe, K. P. Bhatia, N. W. Wood, Parkinson's disease in GTP cyclohydrolase 1 mutation carriers, Brain, 2014, 137, 9, 2480

    CrossRef

  8. 8
    Deborah Elstein, Roy Alcalay, Ari Zimran, The emergence of Parkinson disease among patients with Gaucher disease, Best Practice & Research Clinical Endocrinology & Metabolism, 2014,

    CrossRef

  9. 9
    Dilan Athauda, Thomas Foltynie, The ongoing pursuit of neuroprotective therapies in Parkinson disease, Nature Reviews Neurology, 2014, 11, 1, 25

    CrossRef

  10. 10
    Michelle S. Beavan, Anthony H. V. Schapira, Glucocerebrosidase mutations and the pathogenesis of Parkinson disease, Annals of Medicine, 2013, 45, 8, 511

    CrossRef

  11. 11
    Tom Foltynie, Joshua Kahan, Parkinson’s disease: an update on pathogenesis and treatment, Journal of Neurology, 2013, 260, 5, 1433

    CrossRef

  12. 12
    Eleanna Kara, John Hardy, Henry Houlden, The pallidopyramidal syndromes, Current Opinion in Neurology, 2013, 26, 4, 381

    CrossRef